Credit Suisse’s Pliant Therapeutics PLRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $969K | Buy |
65,025
+3,143
| +5% | +$46.8K | ﹤0.01% | 2284 |
|
|
2023
Q4 | $1.12M | Buy |
61,882
+4,122
| +7% | +$74.6K | ﹤0.01% | 2262 |
|
|
2023
Q3 | $1M | Sell |
57,760
-4,996
| -8% | -$86.6K | ﹤0.01% | 2296 |
|
|
2023
Q2 | $1.14M | Buy |
62,756
+22,281
| +55% | +$404K | ﹤0.01% | 2283 |
|
|
2023
Q1 | $1.08M | Buy |
40,475
+7,008
| +21% | +$186K | ﹤0.01% | 2264 |
|
|
2022
Q4 | $647K | Buy |
+33,467
| New | +$647K | ﹤0.01% | 2603 |
|
|
2022
Q3 | – | Sell |
-13
| Closed | – | – | 4202 |
|
|
2022
Q2 | $0 | Buy |
+13
| New | – | ﹤0.01% | 4198 |
|
|
2021
Q3 | – | Sell |
-7,464
| Closed | -$216K | – | 3567 |
|
|
2021
Q2 | $216K | Sell |
7,464
-728
| -9% | -$21.1K | ﹤0.01% | 3416 |
|
|
2021
Q1 | $322K | Buy |
+8,192
| New | +$322K | ﹤0.01% | 3138 |
|